Combined Tumor Cell and Lysate-Based Vaccines for Immunotherapy of Primary and Recurrent Glioblastoma (GBM)
Apostolos Stathopoulos, Philippe Glorieux, Evangelos M. Rokas, Huub F. J. Savelkoul · 2025
Read Combined Tumor Cell and Lysate-Based Vaccines for Immunotherapy of Primary and Recurrent Glioblastoma (GBM) by Apostolos Stathopoulos, Philippe Glorieux, Evangelos M. Rokas, Huub F. J. Savelkoul (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12691356.txt.
Description
Simple SummaryGlioblastoma (GBM) carries a poor prognosis, and new therapeutic strategies are necessary. Besides peptide- and tumor-lysate-loaded DC vaccination, Cancer Transplant Immune Recognition Therapy (CTIRT) is based on vaccines using isolated tumor cells. CTIRT uses cells and their lysates of the resected tumor cells of the patient and those of other individuals.
Catalog record
| CREATOR | Apostolos Stathopoulos, Philippe Glorieux, Evangelos M. Rokas, Huub F. J. Savelkoul |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |